DnB Asset Management
WX

DnB Asset Management’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

DnB Asset Management’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-41,315
Closed -$1.79M – 485
2015
Q3 		$1.79M Buy
41,315
+4,700
+13% +$198K 0.04% 230
2015
Q2 		$1.55M Buy
36,615
+1,200
+3% +$50.6K 0.03% 261
2015
Q1 		$1.37M Buy
+35,415
New +$1.36M 0.03% 295

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

DnB Asset Management's WX Position: Q4 2015 in Review

DnB Asset Management sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 41,315 shares — an estimated $1.79M sold.

DnB Asset Management first reported a position in WX in Q1 2015 and held it in 3 quarters. The position peaked at $1.79M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • DnB Asset Management reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • DnB Asset Management sold 41,315 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $1.79M.
  • DnB Asset Management first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q1 2015 and held it in 3 quarters.
  • DnB Asset Management's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.79M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on DnB Asset Management's 13F filing for Q4 2015, filed 20 Jan 2016.